All that a 35 million MC — you need to step down, CEO.
How is IHL-42X designed to work?
$IXHL CEO, Joel Latham, explains the rationale behind Incannex’s investigational approach to obstructive sleep apnea and the huge commercial opportunity the company has.
Tune in below!
#Incannex #IHL42X #ObstructiveSleepApnea #DrugDevelopment
18
Love to reach out @ASX_IHL but you have comments turned off. Ridiculous.
$IXHL will be at the 2026 @ASCPorg Annual Meeting in Miami, Florida from May 26th through the 29th. We look forward to connecting with over 900 academic and industry investigators, research pharmacists, and clinicians in the psychopharmacology space.
Reach out to us if you will be in attendance and want to learn more about #IXHL!
68
BANKRUPTCY OR BUYOUT. $IXHL
20K in the whole. It’s my own fault.
54
Absolute scum behind the scenes. Be warned! $IXHL
$IXHL is working to develop novel fixed-dose combination therapies and treatment regimens for patients with obstructive sleep apnea, rheumatoid arthritis, and generalized anxiety disorder.
If you are a physician or patient interested in our investigational therapy #clinicaltrials, visit our site: incannex.com/clinical-trials…
1
67
Should spend more time trying to give back to your fucking shareholders you shagged up the arse without buying dinner. $IXHL
ICYMI $IXHL recently entered into a Partnership Agreement with the @aasmfoundation and will be a sponsor of the AASM Foundation’s Focused Projects Grant for Junior Investigators supporting independent research into the Diagnosis, Management, and Treatment of Sleep Apnea, to be awarded in 2026.
Learn more: ir.incannex.com/news-release…
2
196
$IXHL
Piece of shit CEO & clueless vampires on the payroll.
Need this delisted. Joel you absolute scummer!
62
Thought I read he’d sat down from the board! Gutted they haven’t booted him! $IXHL
GOT my hopes up!
Joel Latham, sat down for a BioPharma Boardroom Q&A to discuss Phase 2 momentum, FDA engagement, and building regulator-ready therapies for sleep apnea, inflammatory disease, and anxiety disorders.
Read more: biopharmaboardroom.com/inter…
71
Last day of the month & it is posted.
What a scam. $IXHL
March is National Sleep Awareness Month! Our program, IHL-42X, is an oral fixed-dose combination therapy of acetazolamide and dronabinol currently in clinical studies for the treatment of obstructive sleep apnea (OSA).
Learn more: bit.ly/44C1HKg
81











